News - UF Innovate

Nash Pharmaceuticals Announces Positive Pre-Clinical Results Showing Lead Compound NP-160 Significantly Reduces NALFD Score and Fibrosis in Non-Alcoholic Fatty Liver Disease (Breathtec Biomedical)

Nash Pharmaceuticals Inc., a wholly owned subsidiary of UF startup Breathtec Biomedical Inc., is pleased to announce that its lead compound for non-alcoholic steatohepatitis (“NASH”)...

Sun BioPharma, Inc. to Present Results of New Pancreatitis Study at American Pancreatic Association Meeting in Miami Beach (Globe Newswire)

UF startup Sun BioPharma, Inc., a clinical stage biopharmaceutical company specializing in disruptive therapeutics for pancreatic diseases, announced that it will present results of a...

ViewRay to Supply UK’s GenesisCare With Country’s First MRIdian Systems (DOTmed)

UF startup ViewRay Inc. is set to deliver the first of Great Britain’s MRIdian MR-guided radiotherapy systems as part of a new partnership between it...

OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD (PR Newswire)

UF startup OxThera AB, a Stockholm-based privately-held biopharmaceutical company and leader in the field of microbiome derived biotherapeutics, announced a poster presentation showing encouraging Oxabact®...

Molekule: An Air Purification Company Scores $25 Million Investment (Tampa Bay Times)

UF startup Molekule, an air filtration company with roots in Tampa Bay, has come a long way in the past few years. The company says...

TAO Connect Receives $141K National Science Foundation Grant to Launch French Translation of Its Digital Therapy System (Globe Newswire)

UF startup TAO Connect, a digital health company aiming to make behavioral health therapy more accessible, efficient and effective, announced it has been awarded $141,799...

UF News

Nash Pharmaceuticals Announces Positive Pre-Clinical Results Showing Lead Compound NP-160 Significantly Reduces NALFD Score and Fibrosis in Non-Alcoholic Fatty Liver Disease (Breathtec Biomedical)

Sun BioPharma, Inc. to Present Results of New Pancreatitis Study at American Pancreatic Association Meeting in Miami Beach (Globe Newswire)

ViewRay to Supply UK’s GenesisCare With Country’s First MRIdian Systems (DOTmed)

OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD (PR Newswire)

Molekule: An Air Purification Company Scores $25 Million Investment (Tampa Bay Times)

TAO Connect Receives $141K National Science Foundation Grant to Launch French Translation of Its Digital Therapy System (Globe Newswire)

Sun BioPharma Announces Leadership Changes (Globe Newswire)

Forward Focused (Business Florida 2019 – The Regions)

A Subscription Prescription To Boost Mental Health Accessibility (PYMNTS.com)

Axogen’s Avance Nerve Graft Receives Regenerative Medicine Advanced Therapy Designation (BioFlorida)